Lifen Zhao

MicroRNA-mediated gene regulation and the resilience of multicellular animals

Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance

Reading the glyco-code: New approaches to studying protein–carbohydrate interactions

Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity

Flavonoid display ability to target microRNAs in cancer pathogenesis

Seeing the forest through the trees: characterizing the glycoproteome

Measuring the multifaceted roles of mucin-domain glycoproteins in cancer

The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

Insights into the role of sialylation in cancer progression and metastasis

Don’t sugarcoat it: How glycocalyx composition influences cancer progression

Glycoproteomics

Glycoengineering: scratching the surface

Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science

Regulation of the tumor suppressor PTEN by natural anticancer compounds

Sweet Control: MicroRNA Regulation of the Glycome

Microbial Biosynthesis of Antibacterial Chrysoeriol in Recombinant Escherichia coli and Bioactivity Assessment

Important Flavonoids and Their Role as a Therapeutic Agent

Functional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4

MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer

MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway

Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer

MicroRNA-33a and let-7e inhibit human colorectal cancer progression by targeting ST8SIA1

Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4

MiRNA expression profiles reveal the involvement of miR-26a, miR-548l and miR-34a in hepatocellular carcinoma progression through regulation of ST3GAL5

miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4

miR-182 and miR-135b Mediate the Tumorigenesis and Invasiveness of Colorectal Cancer Cells via Targeting ST6GALNAC2 and PI3K/AKT Pathway

Selective N-glycan editing on living cell surfaces to probe glycoconjugate function

miR‐4299 mediates the invasive properties and tumorigenicity of human follicular thyroid carcinoma by targeting ST6GALNAC4

Upregulation of microRNA‐135b and microRNA‐182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway

The Mechanism by Which Luteolin Disrupts the Cytoplasmic Membrane of Methicillin-Resistant Staphylococcus aureus

Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs

Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia

MicroRNA‐106b targets FUT6 to promote cell migration, invasion, and proliferation in human breast cancer